Related references
Note: Only part of the references are listed.Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens
Qian Li et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2018)
Insights into the Mechanism of Action of the Two-Peptide Lantibiotic Lacticin 3147
Alireza Bakhtiary et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials
Manuel Montalban-Lopez et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II
Stephen A. Cochrane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery
Auke J. van Heel et al.
ACS SYNTHETIC BIOLOGY (2016)
Semisynthetic Lipopeptides Derived from Nisin Display Antibacterial Activity and Lipid II Binding on Par with That of the Parent Compound
Timo Koopmans et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
A new antibiotic kills pathogens without detectable resistance
Losee L. Ling et al.
NATURE (2015)
The length of a lantibiotic hinge region has profound influence on antimicrobial activity and host specificity
Liang Zhou et al.
FRONTIERS IN MICROBIOLOGY (2015)
The Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane Functions*
Daniela Muench et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature
Paul G. Arnison et al.
NATURAL PRODUCT REPORTS (2013)
Bacteriocins - a viable alternative to antibiotics?
Paul D. Cotter et al.
NATURE REVIEWS MICROBIOLOGY (2013)
BAGEL3: automated identification of genes encoding bacteriocins and (non-)bactericidal posttranslationally modified peptides
Auke J. van Heel et al.
NUCLEIC ACIDS RESEARCH (2013)
Designing and Producing Modified, New-to-Nature Peptides with Antimicrobial Activity by Use of a Combination of Various Lantibiotic Modification Enzymes
Auke J. van Heel et al.
ACS SYNTHETIC BIOLOGY (2013)
Ring A of Nukacin ISK-1: A Lipid II-Binding Motif for Type-A(II) Lantibiotic
Mohammad R. Islam et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria
Catalin Iancu et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2012)
Haloduracin α Binds the Peptidoglycan Precursor Lipid II with 2:1 Stoichiometry
Trent J. Oman et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Activity and Export of Engineered Nisin-(1-22) Analogs
Annechien Plat et al.
POLYMERS (2011)
Production of a Class II Two-Component Lantibiotic of Streptococcus pneumoniae Using the Class I Nisin Synthetic Machinery and Leader Sequence
Joanna A. Majchrzykiewicz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Microbial engineering of dehydro-amino acids and lanthionines in non-lantibiotic peptides
Gert N. Moll et al.
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2010)
Insights into the Mode of Action of the Two-Peptide Lantibiotic Haloduracin
Trent J. Oman et al.
ACS CHEMICAL BIOLOGY (2009)
Specific interaction of the unmodified bacteriocin lactococcin 972 with the cell wall precursor lipid II
Beatriz Martinez et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2008)
The Vancomycin-Nisin(1-12) Hybrid Restores Activity against Vancomycin Resistant Enterococci
Christopher J. Arnusch et al.
BIOCHEMISTRY (2008)
Structure-Activity Relationship Studies of the Two-Component Lantibiotic Haloduracin
Lisa E. Cooper et al.
CHEMISTRY & BIOLOGY (2008)
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
Irith Wiegand et al.
NATURE PROTOCOLS (2008)
Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation
Rick Rink et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic
Amanda L. McClerren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design
Paul D. Cotter et al.
MOLECULAR MICROBIOLOGY (2006)
An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II
Hester E. Hasper et al.
SCIENCE (2006)
The mode of action of the lantibiotic lacticin 3147 -: a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II
Imke Wiedemann et al.
MOLECULAR MICROBIOLOGY (2006)
Lipid II as a target for antibiotics
E Breukink et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Optimization and applications of CDAP labeling for the assignment of cysteines
GD Pipes et al.
PHARMACEUTICAL RESEARCH (2005)
Bacterial lantibiotics: Strategies to improve therapeutic potential
PD Cotter et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2005)
Biosynthesis and mode of action of lantibiotics
C Chatterjee et al.
CHEMICAL REVIEWS (2005)
The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics
STD Hsu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes
E Breukink et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Engineering a disulfide bond and free thiols in the lantibiotic nisin Z
C van Kraaij et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
